Form 144 - Report of proposed sale of securities:
SEC Accession No. 0002002698-24-000082
Filing Date
2024-04-04
Accepted
2024-04-04 14:50:41
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2830
  Complete submission text file 0002002698-24-000082.txt   4273
Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Subject) CIK: 0001720893 (see all company filings)

EIN.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38410 | Film No.: 24822826
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O FOAMIX PHARMACEUTICALS LTD. 2 HOLTZMAN ST, WEIZMANN SCIENCE PARK REHOVOT L3 7670402
Business Address
Wiley Matthew T. (Reporting) CIK: 0001759703 (see all company filings)

Type: 144